Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018

Details for Mechanism ID: 17465
Country/Region: Eswatini
Year: 2016
Main Partner: John Snow, Inc
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: USAID
Total Funding: $6,408,846 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $65,000
Care: TB/HIV (HVTB) $367,284
Testing: HIV Testing and Counseling (HVCT) $854,822
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $382,981
Treatment: Adult Treatment (HTXS) $4,317,628
Treatment: Pediatric Treatment (PDTX) $421,131
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV Age/Sex: <10 Female 2017 20
GEND_GBV Age/Sex: <10 Female 2017 138
GEND_GBV Age/Sex: <10 Male 2017 2
GEND_GBV Age/Sex: <10 Male 2017 13
GEND_GBV Age/Sex: 10-14 Female 2017 20
GEND_GBV Age/Sex: 10-14 Female 2017 140
GEND_GBV Age/Sex: 10-14 Male 2017 3
GEND_GBV Age/Sex: 10-14 Male 2017 20
GEND_GBV Age/Sex: 15-19 Female 2017 18
GEND_GBV Age/Sex: 15-19 Female 2017 133
GEND_GBV Age/Sex: 15-19 Male 2017 3
GEND_GBV Age/Sex: 15-19 male 2017 15
GEND_GBV Age/Sex: 20-24 Female 2017 17
GEND_GBV Age/Sex: 20-24 Female 2017 131
GEND_GBV Age/Sex: 20-24 Male 2017 2
GEND_GBV Age/Sex: 20-24 Male 2017 15
GEND_GBV Age/Sex: 25-49 Female 2017 33
GEND_GBV Age/Sex: 25-49 Female 2017 257
GEND_GBV Age/Sex: 25-49 Male 2017 1
GEND_GBV Age/Sex: 25-49 Male 2017 12
GEND_GBV Age/Sex: 50+ Female 2017 8
GEND_GBV Age/Sex: 50+ Female 2017 83
GEND_GBV Age/Sex: 50+ Male 2017 1
GEND_GBV Age/Sex: 50+ Male 2017 6
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 30
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 218
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 96
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 721
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 32
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 242
GEND_GBV Number of people receiving post-GBV care 2017 128
GEND_GBV Number of people receiving post-GBV care 2017 963
GEND_GBV Sum of Age/Sex Disaggregates 2017 45
GEND_GBV Sum of Age/Sex Disaggregates 2017 311
HTS_TST Age/sex: <1 2017 209
HTS_TST Age/sex: <1 2017 2,170
HTS_TST Age/sex: 1-9 2017 214
HTS_TST Age/sex: 1-9 2017 2,744
HTS_TST Age/sex: 10-14 Female 2017 132
HTS_TST Age/sex: 10-14 Male 2017 4
HTS_TST Age/sex: 10-14 Male 2017 131
HTS_TST Age/sex: 15-19 Female 2017 34
HTS_TST Age/sex: 15-19 Female 2017 1,428
HTS_TST Age/sex: 15-19 Male 2017 633
HTS_TST Age/sex: 20-24 Female 2017 134
HTS_TST Age/sex: 20-24 Female 2017 3,422
HTS_TST Age/sex: 20-24 Male 2017 71
HTS_TST Age/sex: 20-24 Male 2017 1,993
HTS_TST Age/sex: 25-49 Female 2017 232
HTS_TST Age/sex: 25-49 Female 2017 6,754
HTS_TST Age/sex: 25-49 Male 2017 311
HTS_TST Age/sex: 25-49 Male 2017 6,380
HTS_TST Age/sex: 50+ Female 2017 9
HTS_TST Age/sex: 50+ Female 2017 967
HTS_TST Age/sex: 50+ Male 2017 34
HTS_TST Age/sex: 50+ Male 2017 1,097
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 161
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 4,017
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 425
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 11,478
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 842
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 31,224
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 868
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 23,560
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 2,296
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 70,280
HTS_TST Service Delivery Point (Facility): Index testing 2017 117
HTS_TST Service Delivery Point (Facility): Index testing 2017 3,514
HTS_TST Service Delivery Point (Facility): Inpatient 2017 643
HTS_TST Service Delivery Point (Facility): Other PITC 2017 180
HTS_TST Service Delivery Point (Facility): Other PITC 2017 9,880
HTS_TST Service Delivery Point (Facility): Outpatient 2017 665
HTS_TST Service Delivery Point (Facility): Outpatient 2017 22,304
HTS_TST Service Delivery Point (Facility): Pediatric 2017 453
HTS_TST Service Delivery Point (Facility): Pediatric 2017 10,385
HTS_TST Service Delivery Point (Facility): PMTCT 2017 529
HTS_TST Service Delivery Point (Facility): PMTCT 2017 13,186
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 772
HTS_TST Service Delivery Point (Facility): VCT 2017 352
HTS_TST Service Delivery Point (Facility): VCT 2017 9,555
HTS_TST Service Delivery Point (Facility): VMMC 2017 40
HTS_TST Sum of Age/Sex disaggregates 2017 829
HTS_TST Sum of Age/Sex disaggregates 2017 22,937
HTS_TST Sum of Aggregated Age/Sex <15 2017 586
HTS_TST Sum of Aggregated Age/Sex <15 2017 15,495
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 1,710
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 54,784
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 2,296
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 70,279
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 14
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 4
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 4
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 100
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 24
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 19
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 408
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 11
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 89
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 50
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 972
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 37
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 691
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 53
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 4
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 60
HTS_TST_POS Test Result by Age: Positive: <1 2017 32
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 55
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 2
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 162
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 169
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 128
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 4,024
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 94
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 1,954
PMTCT_ART Already on ART at beginning of current pregnancy 2017 84
PMTCT_ART Already on ART at beginning of current pregnancy 2017 2,547
PMTCT_ART New on ART 2017 50
PMTCT_ART New on ART 2017 1,493
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 420
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 13,078
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 120
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 3,794
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 15
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 419
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 43
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 4
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 117
PMTCT_EID Sum of Infant Age disaggregates 2017 135
PMTCT_EID Sum of Infant Age disaggregates 2017 4,213
PMTCT_STAT By Age (DREAMS SNUs ONLY): <15 2017 2
PMTCT_STAT By Age (DREAMS SNUs ONLY): <15 2017 47
PMTCT_STAT By Age (DREAMS SNUs ONLY): 15-19 2017 54
PMTCT_STAT By Age (DREAMS SNUs ONLY): 15-19 2017 905
PMTCT_STAT By Age (DREAMS SNUs ONLY): 20-24 2017 95
PMTCT_STAT By Age (DREAMS SNUs ONLY): 20-24 2017 1,572
PMTCT_STAT By Age (DREAMS SNUs ONLY): 25-49 2017 133
PMTCT_STAT By Age (DREAMS SNUs ONLY): 25-49 2017 2,193
PMTCT_STAT By Age (DREAMS SNUs ONLY): 50+ 2017 3
PMTCT_STAT By Age (DREAMS SNUs ONLY): 50+ 2017 46
PMTCT_STAT By: Known positives at entry 2017 88
PMTCT_STAT By: Known positives at entry 2017 2,745
PMTCT_STAT By: Number of new positives identified 2017 51
PMTCT_STAT By: Number of new positives identified 2017 1,598
PMTCT_STAT Number of new ANC and L&D clients 2017 442
PMTCT_STAT Number of new ANC and L&D clients 2017 13,768
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 420
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 13,078
PMTCT_STAT Required only for DREAMS countries - By known positives: 15-19 2017 2
PMTCT_STAT Required only for DREAMS countries - By known positives: 20-24 2017 12
PMTCT_STAT Required only for DREAMS countries - By known positives: 25-49 2017 46
PMTCT_STAT Required only for DREAMS countries - By new positives: 15-19 2017 5
PMTCT_STAT Required only for DREAMS countries - By new positives: 20-24 2017 14
PMTCT_STAT Required only for DREAMS countries - By new positives: 25-49 2017 15
PMTCT_STAT Required only for DREAMS countries - By new positives: 50+ 2017 1
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: <15 2017 10
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 15-19 2017 31
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 20-24 2017 191
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 25-49 2017 752
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 50+ 2017 15
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: <15 2017 5
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 15-19 2017 75
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 20-24 2017 239
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 25-49 2017 251
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 50+ 2017 12
PMTCT_STAT Sum of Positives Status disaggregates 2017 139
PMTCT_STAT Sum of Positives Status disaggregates 2017 4,343
PMTCT_STAT_den Required only for DREAMS countries - Denominator: <15 2017 3
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15 2017 72
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15-19 2017 969
PMTCT_STAT_den Required only for DREAMS countries - Denominator: 15-19 2017 54
PMTCT_STAT_den Required only for DREAMS countries - Denominator: 20-24 2017 99
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 20-24 2017 1,669
PMTCT_STAT_den Required only for DREAMS countries - Denominator: 25-49 2017 143
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 25-49 2017 2,252
PMTCT_STAT_den Required only for DREAMS countries - Denominator: 50+ 2017 3
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 50+ 2017 50
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 72
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 746
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 60
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 17
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 926
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 19
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 2,007
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 17
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 1,804
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 6,357
TB_SCREENDX [Sub-Disagg of Screen Results] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 73
TB_SCREENDX [Sub-disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 73
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 6,356
TB_SCREENDX Screen Result: Screened Positive for TB 2017 6,690
TB_SCREENDX Screen Results: Screened Positive for TB 2017 79
TB_SCREENDX Screened for TB by Age/Sex: <15 Female 2017 9
TB_SCREENDX Screened for TB by Age/Sex: <15 Male 2017 10
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 341
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 40,838
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 425
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 21,064
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 2,440
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 2,585
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 794
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 66,928
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 87
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1,046
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 76
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 31
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 1,309
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 31
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 2,518
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 32
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 2,624
TX_CURR Age/Sex: <1 2017 291
TX_CURR Age/Sex: <1 2017 4
TX_CURR Age/Sex: <1-9 2017 780
TX_CURR Age/Sex: 1-9 2017 1
TX_CURR Age/Sex: 10-14 Female 2017 170
TX_CURR Age/Sex: 10-14 Female 2017 2
TX_CURR Age/Sex: 10-14 Male 2017 163
TX_CURR Age/Sex: 15-19 Female 2017 6
TX_CURR Age/Sex: 15-19 Female 2017 714
TX_CURR Age/Sex: 15-19 Male 2017 3
TX_CURR Age/Sex: 15-19 Male 2017 118
TX_CURR Age/Sex: 20-24 Female 2017 2,991
TX_CURR Age/Sex: 20-24 Female 2017 43
TX_CURR Age/Sex: 20-24 Male 2017 415
TX_CURR Age/Sex: 20-24 Male 2017 11
TX_CURR Age/Sex: 25-49 Female 2017 13,691
TX_CURR Age/Sex: 25-49 Female 2017 108
TX_CURR Age/Sex: 25-49 Male 2017 8,316
TX_CURR Age/Sex: 25-49 Male 2017 181
TX_CURR Age/Sex: 50+ Female 2017 1,690
TX_CURR Age/Sex: 50+ Female 2017 5
TX_CURR Age/Sex: 50+ Male 2017 1,366
TX_CURR Age/Sex: 50+ Male 2017 6
TX_CURR Aggregated Age/Sex: <15 Female 2017 2,316
TX_CURR Aggregated Age/Sex: <15 Female 2017 10
TX_CURR Aggregated Age/Sex: <15 Male 2017 1,748
TX_CURR Aggregated Age/Sex: <15 Male 2017 9
TX_CURR Aggregated Age/Sex: 15+ Female 2017 40,159
TX_CURR Aggregated Age/Sex: 15+ Female 2017 329
TX_CURR Aggregated Age/Sex: 15+ Male 2017 20,377
TX_CURR Aggregated Age/Sex: 15+ Male 2017 311
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 659
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 64,600
TX_CURR Sum of age/sex disaggregates 2017 832
TX_CURR Sum of Age/Sex disaggregations 2017 9
TX_CURR Sum of Aggregated Age/Sex <15 2017 4,064
TX_CURR Sum of Aggregated Age/Sex <15 2017 19
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 60,536
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 640
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 64,600
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 659
TX_NEW Aggregated Grouping by Age: <1 2017 7
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 7
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 439
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 11
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 511
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 273
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 9,847
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 151
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 3,908
TX_NEW By Age/Sex: <1 2017 68
TX_NEW By Age/Sex: 1-9 2017 6
TX_NEW By Age/Sex: 1-9 2017 101
TX_NEW By Age/Sex: 10-14 Female 2017 25
TX_NEW By Age/Sex: 10-14 Male 2017 29
TX_NEW By Age/Sex: 15-19 Female 2017 5
TX_NEW By Age/Sex: 15-19 Female 2017 238
TX_NEW By Age/Sex: 15-19 Male 2017 3
TX_NEW By Age/Sex: 15-19 Male 2017 21
TX_NEW By Age/Sex: 20-24 Female 2017 34
TX_NEW By Age/Sex: 20-24 Female 2017 799
TX_NEW By Age/Sex: 20-24 Male 2017 7
TX_NEW By Age/Sex: 20-24 Male 2017 65
TX_NEW By Age/Sex: 25-49 Female 2017 102
TX_NEW By Age/Sex: 25-49 Female 2017 2,523
TX_NEW By Age/Sex: 25-49 Male 2017 85
TX_NEW By Age/Sex: 25-49 Male 2017 1,320
TX_NEW By Age/Sex: 50+ Female 2017 5
TX_NEW By Age/Sex: 50+ Female 2017 196
TX_NEW By Age/Sex: 50+ Male 2017 188
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 442
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 14,915
TX_NEW Sum of Age/Sex disaggregates 2017 241
TX_NEW Sum of Age/Sex disaggregates 2017 5,404
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 442
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 14,705
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 659
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 64,600
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 591
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 58,139
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 9
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 2,083
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 8
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 1,576
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 294
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 36,141
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 280
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 18,339
TX_PVLS Numerator: Indication: Routine 2017 501
TX_PVLS Numerator: Indication: Routine 2017 49,417
TX_PVLS Numerator: Indication: Targeted 2017 90
TX_PVLS Numerator: Indication: Targeted 2017 8,722
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 10
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 2,314
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 9
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 1,749
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 329
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 40,155
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 311
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 20,380
TX_PVLS_den Denominator: Indication: Routine 2017 560
TX_PVLS_den Denominator: Indication: Routine 2017 54,909
TX_PVLS_den Denominator: Indication: Targeted 2017 99
TX_PVLS_den Denominator: Indication: Targeted 2017 9,691
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 39
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 66
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 18
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 22
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 161
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 16
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 15
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 514
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 48
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 38
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1,620
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 29
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 808
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 1
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 128
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 119
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 642
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 6
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 202
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 129
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 5,387
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 67
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 2,053
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 204
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 8,283
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 222
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 9,051
TX_RET_den Age/Sex: <1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1
TX_RET_den Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 41
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 71
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 18
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 22
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 175
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 16
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 16
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 563
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 51
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 42
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1,768
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 31
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 885
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 1
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 140
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 131
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 699
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 6
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 216
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 142
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 5,893
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 72
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 2,243
Cross Cutting Budget Categories and Known Amounts Total: $445,935
Motor Vehicles: Purchased $445,935